{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:09Z","timestamp":1790175129008,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10072-020-04988-0","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T10:03:43Z","timestamp":1610618623000},"page":"2045-2057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants"],"prefix":"10.1007","volume":"42","author":[{"given":"Filiz","family":"Hazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aycan","family":"Unalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unsal","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng\u00fc","family":"Demira\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-7776","authenticated-orcid":false,"given":"Sultan","family":"Aydin K\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berk","family":"Ozy\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadri Murat","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6nder","family":"Kalenderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Erku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"G\u00fcr\u00e7\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajlan","family":"T\u00fck\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"4988_CR1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13:834\u2013843","journal-title":"Lancet Neurol"},{"key":"4988_CR2","first-page":"201","volume":"51","author":"National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma","year":"1991","unstructured":"National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma (1991) The consensus development panel (1994). Arch Neurol 51:201\u2013207","journal-title":"Arch Neurol"},{"key":"4988_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2013.6434","volume":"150","author":"F Ferrari","year":"2014","unstructured":"Ferrari F, Masurel A, Olivier-Faivre L, Vabres P (2014) Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1. JAMA Dermatol 150:42\u201346","journal-title":"JAMA Dermatol"},{"key":"4988_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1542\/pir.22.3.82","volume":"22","author":"M Tekin","year":"2001","unstructured":"Tekin M, Bodurtha JN, Riccardi VM (2001) Cafe au lait spots: the pediatrician\u2019s perspective. Pediatr Rev 22:82\u201390","journal-title":"Pediatr Rev"},{"key":"4988_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archdermatol.2009.169","volume":"145","author":"KS Nunley","year":"2009","unstructured":"Nunley KS, Gao F, Albers AC et al (2009) Predictive value of caf\u00e9 au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol 145:883\u2013887","journal-title":"Arch Dermatol"},{"key":"4988_CR6","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s10072-020-04400-x","volume":"41","author":"M Bayat","year":"2020","unstructured":"Bayat M, Bayat A (2020) Neurological manifestations of neurofibromatosis: a review. Neurol Sci 41:2685\u20132690","journal-title":"Neurol Sci"},{"key":"4988_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fneur.2019.01373","volume":"10","author":"E Baudou","year":"2020","unstructured":"Baudou E, Nemmi F, Biotteau M, Maziero S, Peran P, Chaix Y (2020) Can the cognitive phenotype in neurofibromatosis type 1 (NF1) be explained by neuroimaging? A review. Front Neurol 10:1373","journal-title":"Front Neurol"},{"key":"4988_CR8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00247-007-0712-x","volume":"38","author":"JR Lopes Ferraz Filho","year":"2008","unstructured":"Lopes Ferraz Filho JR, Munis MP, Soares Souza A et al (2008) Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38:305\u2013310","journal-title":"Pediatr Radiol"},{"key":"4988_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181\u2013186","journal-title":"Science"},{"key":"4988_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF et al (1990) A maj\u00f6r segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193\u2013201","journal-title":"Cell"},{"key":"4988_CR11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","volume":"63","author":"GA Martin","year":"1990","unstructured":"Martin GA, Viskochil D, Bollag G et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843\u2013849","journal-title":"Cell"},{"key":"4988_CR12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O'Connell P, Viskochil D et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608","journal-title":"Cell"},{"key":"4988_CR13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/351576a0","volume":"351","author":"G Bollag","year":"1991","unstructured":"Bollag G, McCormick F (1991) Differential regulation of ras GAP and neurofibromatosis gene product activities. Nature 351:576\u2013579","journal-title":"Nature"},{"key":"4988_CR14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","volume":"11","author":"DA Marchuk","year":"1991","unstructured":"Marchuk DA, Saulino AM, Tavakkol R et al (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11:931\u2013940","journal-title":"Genomics"},{"key":"4988_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/humu.20246","volume":"26","author":"H Yu","year":"2005","unstructured":"Yu H, Zhao X, Su B, Li D, Xu Y, Luo S, Xiao C, Wang W (2005) Expression of NF1 pseudogenes. Hum Mutat 26:487\u2013488","journal-title":"Hum Mutat"},{"key":"4988_CR16","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1136\/jmg.40.10.e109","volume":"40","author":"B Castle","year":"2003","unstructured":"Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M (2003) Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 40:e109","journal-title":"J Med Genet"},{"key":"4988_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/bjmg-2017-0008","volume":"20","author":"SD Ulusal","year":"2017","unstructured":"Ulusal SD, G\u00fcrkan H, Atl\u0131 E et al (2017) Genetic analyses of the NF1 gene in Turkish neurofibromatosis type I patients and definition of three novel variants. Balkan J Med Genet 20:13\u201320","journal-title":"Balkan J Med Genet"},{"key":"4988_CR18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ejhg.2008.134","volume":"16","author":"E Pasmant","year":"2008","unstructured":"Pasmant E, de Saint-Trivier A, Laurendeau I, Dieux-Coeslier A, Parfait B, Vidaud M, Vidaud D, Bi\u00e8che I (2008) Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient. Eur J Hum Genet 16:1459\u20131466","journal-title":"Eur J Hum Genet"},{"key":"4988_CR19","volume":"95","author":"L Zhu","year":"2016","unstructured":"Zhu L, Zhang Y, Tong H, Shao M, Gu Y, du X, Wang P, Shi L, Zhang L, Bi M, Wang X, Zhang G (2016) Clinical and molecular characterization of NF1 patients: single-center experience of 32 patients from China. Medicine (Baltimore) 95:e3043","journal-title":"Medicine (Baltimore)"},{"key":"4988_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, ACMG Laboratory Quality Assurance Committee et al (2015) ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"issue":"Chapter 7","key":"4988_CR21","first-page":"Unit7.20","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 76(Chapter 7):Unit7.20","journal-title":"Curr Protoc Hum Genet"},{"key":"4988_CR22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073\u20131081","journal-title":"Nat Protoc"},{"key":"4988_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M et al (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361\u2013362","journal-title":"Nat Methods"},{"key":"4988_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17530059.2010.494660","volume":"4","author":"M Upadhyaya","year":"2010","unstructured":"Upadhyaya M (2010) Neurofibromatosis type 1: diagnosis and recent advances. Expert Opin Med Diagn 4:307\u2013322","journal-title":"Expert Opin Med Diagn"},{"key":"4988_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12:1\u201311","journal-title":"Genet Med"},{"key":"4988_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mgg3.161","volume":"3","author":"D Bianchessi","year":"2015","unstructured":"Bianchessi D, Morosini S, Saletti V, Ibba MC, Natacci F, Esposito S, Cesaretti C, Riva D, Finocchiaro G, Eoli M (2015) 126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genomic Med 3:513\u2013525","journal-title":"Mol Genet Genomic Med"},{"key":"4988_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ahg.12272","volume":"82","author":"C Palma Milla","year":"2018","unstructured":"Palma Milla C, Lezana Rosales JM, L\u00f3pez Montiel J et al (2018) Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients. Ann Hum Genet 82:425\u2013436","journal-title":"Ann Hum Genet"},{"key":"4988_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0037-1620239","volume":"49","author":"C Barrea","year":"2018","unstructured":"Barrea C, Vaessen S, Bulk S et al (2018) Phenotype-genotype correlation in children with neurofibromatosis type 1. Neuropediatrics 49:180\u2013184","journal-title":"Neuropediatrics"},{"key":"4988_CR29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1399-0004.2005.00410.x","volume":"67","author":"S Alwan","year":"2005","unstructured":"Alwan S, Tredwell SJ, Friedman JM (2005) Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67:378\u2013390","journal-title":"Clin Genet"},{"key":"4988_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","volume":"85","author":"R Van Minkelen","year":"2014","unstructured":"Van Minkelen R, van Bever Y, Kromosoeto JN et al (2014) A clinical and genetic overview of 18\u2009years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet 85:318\u2013327","journal-title":"Clin Genet"},{"key":"4988_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","volume":"395","author":"M Tsipi","year":"2018","unstructured":"Tsipi M, Poulou M, Fylaktou I, Kosma K, Tsoutsou E, Pons MR, Kokkinou E, Kitsiou-Tzeli S, Fryssira H, Tzetis M (2018) Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA. J Neurol Sci 395:95\u2013105","journal-title":"J Neurol Sci"},{"key":"4988_CR32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/genes10080580","volume":"10","author":"T Giugliano","year":"2019","unstructured":"Giugliano T, Santoro C, Torella A et al (2019) Clinical and genetic findings in children with neurofibromatosis type 1, Legius syndrome, and other related neurocutaneous disorders. Genes (Basel) 10:580","journal-title":"Genes (Basel)"},{"key":"4988_CR33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"LM Messiaen","year":"2000","unstructured":"Messiaen LM, Callens T, Mortier G et al (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541\u2013555","journal-title":"Hum Mutat"},{"key":"4988_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/humu.20103","volume":"24","author":"A Zatkova","year":"2004","unstructured":"Zatkova A, Messiaen L, Vandenbroucke I, Wieser R, Fonatsch C, Krainer AR, Wimmer K (2004) Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum.Mutat 24:491\u2013501","journal-title":"Hum.Mutat"},{"key":"4988_CR35","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2003.011890","volume":"41","author":"C Mattocks","year":"2004","unstructured":"Mattocks C, Baralle D, Tarpey P, ffrench-Constant C, Bobrow M, Whittaker J (2004) Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11\u201317 distinct from the GAP related domain. J Med Genet 41:e48","journal-title":"J Med Genet"},{"key":"4988_CR36","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1038\/srep11291","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tong H, Fu X et al (2015) Molecular characterization of NF1 and neurofibromatosis type 1 genotype-phenotype correlations in a Chinese population. Sci Rep 5:11291","journal-title":"Sci Rep"},{"key":"4988_CR37","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","volume":"40","author":"E Ars","year":"2003","unstructured":"Ars E, Kruyer H, Morell M, Pros E, Serra E, Ravella A, Estivill X, L\u00e1zaro C (2003) Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40:e82","journal-title":"J Med Genet"},{"key":"4988_CR38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","volume":"49","author":"E Pasmant","year":"2012","unstructured":"Pasmant E, Vidaud M, Vidaud D, Wolkenstein P (2012) Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 49:483\u2013489","journal-title":"J Med Genet"},{"key":"4988_CR39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/374821","volume":"72","author":"T De Raedt","year":"2003","unstructured":"De Raedt T, Brems H, Wolkenstein P et al (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:288\u20131292","journal-title":"Am J Hum Genet"},{"key":"4988_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/humu.10299","volume":"23","author":"L Kluwe","year":"2004","unstructured":"Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, Mautner VF (2004) Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 23:111\u2013116","journal-title":"Hum Mutat"},{"key":"4988_CR41","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bi\u00e8che I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D, members of the NF France Network (2010) NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31:E1506\u2013E1518","journal-title":"Hum Mutat"},{"key":"4988_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cge.12632","volume":"89","author":"X Ning","year":"2016","unstructured":"Ning X, Farschtschi S, Jones A, Kehrer-Sawatzki H, Mautner VF, Friedman JM (2016) Growth in neurofibromatosis 1 microdeletion patients. Clin Genet 89:351\u2013354","journal-title":"Clin Genet"},{"key":"4988_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN (2017) Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet 136:349\u2013376","journal-title":"Hum Genet"},{"key":"4988_CR44","unstructured":"Friedman JM. Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews. University of Washington, pp 1993\u20132020"},{"key":"4988_CR45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","volume":"167","author":"CE Prada","year":"2015","unstructured":"Prada CE, Hufnagel RB, Hummel TR et al (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 167:851\u2013856","journal-title":"J Pediatr"},{"key":"4988_CR46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-018-0811-9","volume":"13","author":"L Sellmer","year":"2018","unstructured":"Sellmer L, Farschtschi S, Marangoni M, Heran MKS, Birch P, Wenzel R, Mautner VF, Friedman JM (2018) Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1. Orphanet J Rare Dis 13:62","journal-title":"Orphanet J Rare Dis"},{"key":"4988_CR47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpn.2015.12.002","volume":"20","author":"G Blanchard","year":"2016","unstructured":"Blanchard G, Lafforgue MP, Lion-Fran\u00e7ois L et al (2016) Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol 20:275\u2013281","journal-title":"Eur J Paediatr Neurol"},{"key":"4988_CR48","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","volume":"54","author":"K DeBella","year":"2000","unstructured":"DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54:1646\u20131650","journal-title":"Neurology"},{"key":"4988_CR49","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00330-004-2433-y","volume":"15","author":"HJ Mentzel","year":"2005","unstructured":"Mentzel HJ, Seidel J, Fitzek C et al (2005) Pediatric brain MRI in neurofibromatosis type I. Eur Radiol 15:814\u2013822","journal-title":"Eur Radiol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04988-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:40:29Z","timestamp":1646415629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04988-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4988"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04988-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no financial relationships relevant to this article to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosure"}}]}}